TrialBritish journal of clinical pharmacology2014

Human disposition, metabolism and excretion of etamicastat, a reversible, peripherally selective dopamine β-hydroxylase inhibitor.

Ana I Loureiro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.